Jeet Biswas MD, PhD
banner
jeetb.bsky.social
Jeet Biswas MD, PhD
@jeetb.bsky.social
Oncology fellow in Abdel-Wahab lab at MSKCC studying RNA binding proteins in myeloid malignancies, formerly of Singer lab at Einstein.
Reposted by Jeet Biswas MD, PhD
🚀 NY-CURES Launch — Championing State-Wide Investment in Science! 🚀

Our new coalition advocates for sustained public support of New York’s vibrant biomedical research ecosystem — creating cures, economic gains & strengthening communities.

Sign up. Stay informed. Join the movement: www.nycures.org/
September 4, 2025 at 4:32 PM
Reposted by Jeet Biswas MD, PhD
In this review, @jeetb.bsky.social et al. describe the current state of understanding of how #RNA processing is dysregulated in #cancer and how this knowledge is being harnessed for therapeutic intent. rupress.org/jem/article/...

📘 In JEM Cancer Collection rupress.org/jem/collecti...

#AACR25
April 23, 2025 at 5:16 PM
Reposted by Jeet Biswas MD, PhD
Excited to share Benson’s and Maria’s work in collab w/Kostas Tzelepis: we found the nucleolar protein NPM1 is a marker of AML and can be targeted therapeutically

connecting ‘cell surface RNA biology’ to cancer biology

@natbiotech.nature.com
www.nature.com/articles/s41...
April 23, 2025 at 11:44 AM
Reposted by Jeet Biswas MD, PhD
“Without the funding that went into developing CAR T-cell therapy, I and a lot of other kids would not be here today.” - Emily Whitehead. www.cnn.com/2025/03/07/h...
Cancer survivor warns against threats to health funding | CNN
Emily Whitehead and Tom Whitehead join The Lead
www.cnn.com
March 10, 2025 at 4:27 PM
Reposted by Jeet Biswas MD, PhD
Could one envision a synthetic receptor technology that is fully programmable, able to detect diverse extracellular antigens – both soluble and cell-attached – and convert that recognition into a wide range of intracellular responses, from gene expression and real-time fluorescence to modulation..
December 4, 2024 at 4:05 PM
Reposted by Jeet Biswas MD, PhD
Here's the list of @mskcancercenter.bsky.social current and former colleagues on @bsky.app Comment if you want to be added #MedSky #OncSky go.bsky.app/Aobpj7f
November 25, 2024 at 1:29 PM
Reposted by Jeet Biswas MD, PhD
Among so many amazing starter packs, but none focused on RNA splicing - so we made one!

Check out the accounts we’ve included so far, and let us know if you’d like to be added or have suggestions!

go.bsky.app/TigRnmC

#rnasplicing
November 17, 2024 at 10:13 AM
Reposted by Jeet Biswas MD, PhD
Here is a paper where I would just like to say "Thank you" to the authors.

I thoroughly enjoyed this.

I hope you do too.

#GENESky
#RNAsky
#CANsky
#genomics
#bioinformatics
🧪
🧬💻
🔎 microproteins

www.cell.com/cell-reports...
RNA splicing junction landscape reveals abundant tumor-specific transcripts in human cancer
Li et al. thoroughly analyzed RNA splicing junctions in 34,775 samples and identified 29,051 tumor-specific transcripts that may serve as cancer driver genes, neoantigens, and circulating biomarkers.
www.cell.com
November 16, 2024 at 7:54 PM
Reposted by Jeet Biswas MD, PhD
Happy Friday! New preprint to discuss, led by @ekaplan.bsky.social, entitled "Activity-based selection for enhanced base editor mutational scanning"

www.biorxiv.org/content/10.1...

A thread...
Activity-based selection for enhanced base editor mutational scanning
Base editing is a CRISPR-based technology that enables high-throughput, nucleotide-level functional interrogation of the genome, which is essential for understanding the genetic basis of human disease...
www.biorxiv.org
November 15, 2024 at 1:18 PM
Reposted by Jeet Biswas MD, PhD
The Night Science Podcast is now on Bluesky!
bsky.app/profile/nigh...
Here's a starter pack to connect with some of our previous guests!
go.bsky.app/Q5vFUQk
November 15, 2024 at 1:27 PM